Skip to main content
TipRanks
Go Ultimate75% OFF

Sarepta Therapeutics (0L35) Income Statement

3 Followers

Sarepta Therapeutics Income Statement

Last quarter (Q3 2026), Sarepta Therapeutics's total revenue was $381.35M, a decrease of 4.51% from the same quarter last year. In Q3, Sarepta Therapeutics's net income was $-28.46M. See Sarepta Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
$ 2.20B$ 1.90B$ 1.24B$ 933.01M$ 701.89M
$ 1.32B$ 1.58B$ 1.09B$ 793.02M$ 604.84M
$ 1.97B$ 1.36B$ 1.36B$ 1.33B$ 1.06B
Depreciation and Amortization$ 44.52M$ 37.72M$ 44.40M$ 41.86M$ 38.02M
$ -647.97M$ 316.89M$ -453.69M$ -594.85M$ -317.41M
$ -657.77M$ 218.08M$ -267.82M$ -536.20M$ -459.71M
$ -44.45M$ 42.69M$ -252.27M$ -153.76M$ 40.76M
$ -702.23M$ 260.77M$ -520.10M$ -689.96M$ -418.95M
$ -713.41M$ 235.24M$ -535.98M$ -703.49M$ -418.78M
Per Share Metrics
Basic EPS$ -7.13$ 2.47$ -5.80$ -8.03$ -5.15
Diluted EPS$ -7.13$ 2.34$ -5.80$ -8.03$ -5.15
Weighted Average Shares Outstanding104.79M95.08M92.40M87.56M81.26M
Weighted Average Shares Outstanding (Diluted)104.79M107.88M92.40M87.56M81.26M

Currency in USD

Sarepta Therapeutics Earnings and Revenue History

-1.2B01.2B2.4B-200 %-100 %0 %100 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin